Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$35.66 - $42.94 $981,791 - $1.18 Million
-27,532 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$23.7 - $39.27 $652,508 - $1.08 Million
27,532 New
27,532 $1.08 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Tiger Pacific Capital LP Portfolio

Follow Tiger Pacific Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiger Pacific Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Tiger Pacific Capital LP with notifications on news.